nach oben

Clinical Rheumatology

Erschienen in:

23.05.2019 | Case Based Review

Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review

verfasst von: Alireza Ashiri, Molouk Beiromvand, Abdollah Khanzadeh

Erschienen in: Clinical Rheumatology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Strongyloides stercoralis (S. stercoralis), a human intestinal nematode, can lead to hyper/disseminated (HD) infection in patients treated with corticosteroids. Here, we report a case of strongyloidiasis in a 58-year-old female with a history of rheumatoid arthritis (RA) and type 2 diabetes mellitus (T2DM). The patient presented with abdominal pain and gastrointestinal (GI) bleeding. Stool was negative for parasitic agents in the first direct smear examination, and the patient with the probable diagnosis of Helicobacter pylori (H. pylori) infection or Crohn’s disease received antibiotics and corticosteroids. Parasitic agents were not detected in further direct stool examinations, and the patient with the diagnosis of pneumonia, chronic kidney disease (CKD), ulcerative colitis, sepsis, and candidiasis received fungal, antibiotic, and corticosteroids medications. Low sensitivity of direct smear and the lack of using two methods in diagnosing intestinal parasitic infections led to delayed detection. In the fourth direct stool examination, rhabditiform larva of S. stercoralis was reported. The treatment of corticosteroids was discontinued and albendazole was started. A literature review was conducted by searching Medline, Embase, Scopus, and Web of Science with the keywords S. stercoralis, strongyloidiasis, RA, and T2DM. Our case indicates that screening S. stercoralis infection in high-risk groups, especially those who are candidates for corticosteroids medications, must be implemented using at least two diagnostic techniques.

Echazú A, Juarez M, Vargas PA, Cajal SP, Cimino RO, Heredia V, Caropresi S, Paredes G, Arias LM, Abril M, Gold S, Lammie P, Krolewiecki AJ (2017) Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: a community-based pragmatic study. PLoS Negl Trop Dis 11:e0006003. https://doi.org/10.1371/journal.pntd.0006003 CrossRefPubMedPubMedCentral

World Health Organization (2018) Soil-transmitted helminth infections

Jenkins TP, Formenti F, Castro C, Piubelli C, Perandin F, Buonfrate D, Otranto D, Griffin JL, Krause L, Bisoffi Z, Cantacessi C (2018) A comprehensive analysis of the faecal microbiome and metabolome of Strongyloides stercoralis infected volunteers from a non-endemic area. Sci Rep 8:15651. https://doi.org/10.1038/s41598-018-33937-3 CrossRefPubMedPubMedCentral

Hays R, Giacomin P, Olma L, Esterman A, McDermott R (2017) The relationship between treatment for Strongyloides stercoralis infection and type 2 diabetes mellitus in an Australian Aboriginal population: a three-year cohort study. Diabetes Res Clin Pract 134:8–16. https://doi.org/10.1016/j.diabres.2017.09.012 CrossRefPubMed

Robertson GJ, Koehler AV, Gasser RB, Watts M, Norton R, Bradbury RS (2017) Application of PCR-based tools to explore Strongyloides infection in people in parts of Northern Australia. Trop Med Infect Dis 2:62. https://doi.org/10.3390/tropicalmed2040062 CrossRefPubMedCentral

Khadka P, Khadka P, Thapaliya J, Karkee DB (2018) Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease. JMM Case Rep 5:e005165-e.10.1099/jmmcr.0.005165CrossRef

Nutman TB (2017) Human infection with Strongyloides stercoralis and other related Strongyloides species. Parasitology 144:263–273. https://doi.org/10.1017/S0031182016000834

Grossi P, Lombardi D, Petrolo A, Rovelli C, Di Rosa Z, Perriccioli G et al (2018) Strongyloides stercoralis hyperinfection in an HIV-infected patient successfully treated with subcutaneous ivermectin. Trop Med Infect Dis 3:46CrossRef

Amor A, Rodriguez E, Saugar JM, Arroyo A, López-Quintana B, Abera B, Yimer M, Yizengaw E, Zewdie D, Ayehubizu Z, Hailu T, Mulu W, Echazú A, Krolewieki AJ, Aparicio P, Herrador Z, Anegagrie M, Benito A (2016) High prevalence of Strongyloides stercoralis in school-aged children in a rural highland of north-western Ethiopia: the role of intensive diagnostic work-up. Parasites Vectors 9:617. https://doi.org/10.1186/s13071-016-1912-8 CrossRefPubMedPubMedCentral

10.

Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H et al (2013) Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7:e2288-e.10.1371/journal.pntd.0002288CrossRef

11.

Fardet L, Généreau T, Cabane J, Kettaneh A (2006) Severe strongyloidiasis in corticosteroid-treated patients. Clin Microbiol Infect 12:945–947. https://doi.org/10.1111/j.1469-0691.2006.01443.x CrossRefPubMed

12.

Santiago M, Leitão B (2009) Prevention of Strongyloides hyperinfection syndrome: a rheumatological point of view. Eur J Intern Med 20:744–748. https://doi.org/10.1016/j.ejim.2009.09.001 CrossRefPubMed

13.

de Souza JN, Ines Ede J, Santiago M, Teixeira MC, Soares NM (2016) Strongyloides stercoralis infection in patients with systemic lupus erythematosus: diagnosis and prevention of severe strongyloidiasis. Int J Rheum Dis 19:700–705. https://doi.org/10.1111/1756-185x.12644 CrossRefPubMed

14.

Yanik K, Karadag A, Odabasi H, Unal N, Altintop L, Hokelek M (2013) [Strongyloides stercoralis in a patient with ankylosing spondylitis: case report]. Turkiye Parazitol Derg 37:143–146. https://doi.org/10.5152/tpd.2013.31

15.

Yung EE, Lee CMKL, Boys J, Grabo DJ, Buxbaum JL, Chandrasoma PT (2014) Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus. Am J Trop Med Hyg 91:806–809. https://doi.org/10.4269/ajtmh.14-0228 CrossRefPubMedPubMedCentral

16.

Khaliq MF, Ihle RE, Perry J (2018) Immunosuppression with antitumour necrosis factor therapy leading to Strongyloides hyperinfection syndrome. Case Rep Infect Dis 2018:6341680. https://doi.org/10.1155/2018/6341680 CrossRefPubMedPubMedCentral

17.

Mejia R, Nutman TB (2012) Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25:458–463. https://doi.org/10.1097/QCO.0b013e3283551dbd CrossRefPubMedPubMedCentral

18.

Montini F, Grenouillet F, Capellier G, Piton G (2015) Strongyloidiasis: an unusual cause of septic shock with pneumonia and enteropathy in western countries. BMJ Case Rep 2015:bcr2014209028. https://doi.org/10.1136/bcr-2014-209028 CrossRefPubMedPubMedCentral

19.

Ting YM (2000) Pulmonary strongyloidiasis-case report of 2 cases. Kaohsiung J Med Sci 16:269–274PubMed

20.

Peng SL (2002) Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum 31:228–247CrossRef

21.

Buskila D, Sukenik S, Klein M, Horowitz J (1992) Polyarthritis associated with hydatid disease (echinococcosis) of the liver. Clin Rheumatol 11:286–287CrossRef

22.

Mohanty S, Samprathi M, Parija S (2017) Reactive arthritis associated with Strongyloides stercoralis: report of an uncommon relation. Trop parasitol 7:117–119. https://doi.org/10.4103/tp.TP_9_17 CrossRefPubMedPubMedCentral

23.

Zeitler K, Jariwala R, Restrepo-Jaramillo R, Kapadia S, Casanas B, Alrabaa S, Sriaroon C (2018) Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population. BMJ Case Rep 2018. https://doi.org/10.1136/bcr-2017-223138

24.

Laing R, Gillan V, Devaney E (2017) Ivermectin- old drug, new tricks? Trends Parasitol 33:463–472. https://doi.org/10.1016/j.pt.2017.02.004 CrossRefPubMedPubMedCentral

25.

Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC, Jr., Terashima A, Samalvides F, et al (2016) Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev CD007745-CD.https://doi.org/10.1002/14651858.CD007745.pub3

26.

Kathamuthu GR, Munisankar S, Sridhar R, Baskaran D, Babu S (2019) Helminth mediated modulation of the systemic and mycobacterial antigen – stimulated cytokine profiles in extra-pulmonary tuberculosis. PLoS Negl Trop Dis 13:e0007265. https://doi.org/10.1371/journal.pntd.0007265 CrossRefPubMedPubMedCentral

27.

Coulter C, Walker DG, Gunsberg M, Brown IG, Bligh JF, Prociv P (1992) Successful treatment of disseminated strongyloidiasis. Med J Aust 157:331–332CrossRef

28.

Mariotta S, Pallone G, Li Bianchi E, Gilardi G, Bisetti A (1996) Strongyloides stercoralis hyperinfection in a case of idiopathic pulmonary fibrosis. Panminerva Med 38:45–47PubMed

29.

Kim J, Joo H-S, Kim D-H, Lim H, Kang Y-H, Kim M-S (2003) A case of gastric strongyloidiasis in a Korean patient. Korean J Parasitol 41:63–67. https://doi.org/10.3347/kjp.2003.41.1.63 CrossRefPubMedPubMedCentral

30.

Koh MS, Leng PH, Eng P, Hwang J (2004) An unusual cause of pulmonary haemorrhage in a patient with rheumatoid arthritis. Ann Acad Med Singap 33:365–367PubMed

31.

Kim J, Joo H-S, Ko H-M, Na M-S, Hwang S-H, Im J-C (2005) A case of fatal hyperinfective strongyloidiasis with discovery of autoinfective filariform larvae in sputum. Korean J Parasitol 43:51–55. https://doi.org/10.3347/kjp.2005.43.2.51 CrossRefPubMedPubMedCentral

32.

Boatright MD, Wang BW (2005) Clinical infection with Strongyloides stercoralis following etanercept use for rheumatoid arthritis. Arthritis Rheum 52:1336–1337. https://doi.org/10.1002/art.20882 CrossRefPubMed

33.

Krishnamurthy R, Dincer HE, Whittemore D (2007) Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. J Clin Rheumatol 13:150–152. https://doi.org/10.1097/RHU.0b013e3180690933 CrossRefPubMed

34.

Das P, Raghu P, Amit Kumar D, Garg P (2007) Strongyloides hyperinfection in rheumatoid arthritis. Int J Surg Pathol 15:391–392. https://doi.org/10.1177/1066896907302241 CrossRefPubMed

35.

Ben-Horin S, Barshack I, Chowers Y, Mouallem M (2008) Flare-up of ulcerative colitis after systemic corticosteroids: a strong case for Strongyloides. World J Gastroenterol 14:4413–4415. https://doi.org/10.3748/wjg.14.4413 CrossRefPubMedPubMedCentral

36.

Azira NM, Zeehaida M (2010) Strongyloides stercoralis hyperinfection in a diabetic patient: case report. Trop Biomed 27:115–119PubMed

37.

Shafaghi A, Akhavan K, Hajizade H, Mansour-Ghanaei F (2010) Disseminated strongyloidiasis following high-dose prednisolone administration. Am J Case Rep 11:74–77

38.

Altintop L, Cakar B, Hokelek M, Bektas A, Yildiz L, Karaoglanoglu M (2010) Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report. Ann Clin Microbiol Antimicrob 9:27. https://doi.org/10.1186/1476-0711-9-27 CrossRefPubMedPubMedCentral

39.

Islam QT, Siddiqui MR, Rahman MA, Ahmed SS (2011) Happy ending of life-threatening upper GI bleeding. BMJ Case Rep 2011:bcr0720114435. https://doi.org/10.1136/bcr.07.2011.4435 CrossRefPubMedPubMedCentral

40.

Won EJ, Jeon J, Koh Y-I, Ryang DW (2015) Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. Korean J Parasitol 53:223–226. https://doi.org/10.3347/kjp.2015.53.2.223 CrossRefPubMedPubMedCentral

41.

Najjari M, Ebrahimipour M, Kaheh A, Karimazar M (2016) Disseminated strongyloidiasis in an immunodeficient patient (pemphigus vulgaris) due to corticosteroid therapy: a case report. Iranian J Parasitol 11:411–416

42.

Poveda J, El-Sharkawy F, Arosemena LR, Garcia-Buitrago MT, Rojas CP (2017) Strongyloides colitis as a harmful mimicker of inflammatory bowel disease. Case Rep Pathol 2017:2560719. https://doi.org/10.1155/2017/2560719 CrossRefPubMedPubMedCentral

43.

Dahal S, Lederman J, Berman J, Viseroi M, Jesmajian S (2017) A case of bacteremia and meningitis associated with piperacillin-tazobactam nonsusceptible, ceftriaxone susceptible Escherichia coli during Strongyloides hyperinfection in an immunocompromised host. Case Rep Infect Dis 2017:8634717. https://doi.org/10.1155/2017/8634717 CrossRefPubMedPubMedCentral

44.

Al Hadidi M, Shaaban H, Jumean KH, Peralta P (2018) Loeffler’s syndrome secondary to hyperinfection by Strongyloides stercoralis associated with methotrexate in a patient with rheumatoid arthritis. J Glob Infect Dis 10:29–30. https://doi.org/10.4103/jgid.jgid_69_17 CrossRefPubMedPubMedCentral

45.

Cohen R, Finn T, Babushkin F, Shapiro M, Uda M, Grossman T (2018) Streptococcus pyogenes bacteremia and toxic shock syndrome related to Strongyloides stercoralis hyperinfection: a case report. J Med Case Rep 12:346. https://doi.org/10.1186/s13256-018-1885-7 CrossRefPubMedPubMedCentral

46.

Sharifdini M, Hesari A, Mahdavi SA, Alipour A, Kia EB (2018) Strongyloides stercoralis hyperinfection in an unconscious diabetic patient with dermatomyositis. Indian J Pathol Microbiol 61:109–112. https://doi.org/10.4103/ijpm.ijpm_734_16 CrossRefPubMed

Titel: Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review
verfasst von: Alireza Ashiri
Molouk Beiromvand
Abdollah Khanzadeh
Publikationsdatum: 23.05.2019
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 11/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-019-04611-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Quality and readability of online information on ankylosing spondylitis

Sirt1 inhibits gouty arthritis via activating PPARγ

Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders

The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis

A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis–associated interstitial lung disease with progressive fibrosis